Stryker Corporation (NYSE: SYK) is a leading medical technology company that designs, manufactures, and sells a wide range of products and services for hospitals, surgeons, and patients. The company's products include implants, instruments, medical equipment, and software.
Stryker is a well-respected company with a strong track record of financial performance. The company has been profitable for over 20 years, and its revenue has grown steadily over that time. In 2019, Stryker reported revenue of \$13.6 billion and net income of \$2.4 billion.
The price of Stryker stock is influenced by a number of factors, including:
Stryker stock has performed well over the past decade. The stock has outperformed the S&P 500 index, and it has also outperformed many of its competitors. In the past 10 years, Stryker stock has gained over 200%.
The outlook for Stryker stock is positive. The company is well-positioned to continue to grow its revenue and earnings in the future. Stryker is investing heavily in research and development, and it is constantly launching new products and services. The company is also expanding its international presence, which will help to drive growth in the future.
Stryker stock is a good investment for investors who are looking for a company with a strong track record of financial performance and a bright future. The company is well-positioned to continue to grow its revenue and earnings in the future, and its stock is a good value at its current price.
Year | Revenue | Net Income |
---|---|---|
2019 | \$13.6 billion | \$2.4 billion |
2018 | \$12.4 billion | \$2.2 billion |
2017 | \$11.4 billion | \$2.0 billion |
2016 | \$10.4 billion | \$1.8 billion |
2015 | \$9.5 billion | \$1.6 billion |
Year | Stock Price |
---|---|
2019 | \$160.00 |
2018 | \$140.00 |
2017 | \$120.00 |
2016 | \$100.00 |
2015 | \$80.00 |
Company | Revenue | Net Income |
---|---|---|
Johnson & Johnson | \$75.3 billion | \$14.7 billion |
Medtronic | \$26.0 billion | \$4.4 billion |
Abbott Laboratories | \$23.5 billion | \$5.2 billion |
Region | Revenue |
---|---|
United States | \$7.8 billion |
Europe | \$3.2 billion |
Asia | \$1.8 billion |
Other | \$0.8 billion |
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-10-08 09:53:57 UTC
2024-10-14 17:57:48 UTC
2024-12-06 16:25:19 UTC
2024-12-12 17:13:47 UTC
2024-12-18 04:38:14 UTC
2024-10-03 16:53:07 UTC
2024-10-24 11:07:37 UTC
2024-10-08 09:49:29 UTC
2025-01-06 06:15:39 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:37 UTC
2025-01-06 06:15:37 UTC
2025-01-06 06:15:33 UTC
2025-01-06 06:15:33 UTC